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Experience-dependent plasticity is the ability of brain circuits to undergo molecular,
structural and functional changes as a function of neural activity. Neural activity
continuously shapes our brain during all the stages of our life, from infancy through
adulthood and beyond. Epigenetic modifications of histone proteins and DNA seem to
be a leading molecular mechanism to modulate the transcriptional changes underlying
the fine-tuning of synaptic connections and circuitry rewiring during activity-dependent
plasticity. The recent discovery that cytosine methylation is an epigenetic mark
particularly dynamic in brain cells has strongly increased the interest of neuroscientists in
understanding the role of covalent modifications of DNA in activity-induced remodeling
of neuronal circuits. Here, we provide an overview of the role of DNA methylation and
hydroxylmethylation in brain plasticity both during adulthood, with emphasis on learning
and memory related processes, and during postnatal development, focusing specifically
on experience-dependent plasticity in the visual cortex.
Keywords: epigenetics, gene transcription, ocular dominance plasticity, cytosine hydroxylmethylation,
neurodevelopmental disorders
Introduction
Phenotype is the result of the dynamic and continuous interaction between genes and environment.
Our brain is an excellent system to assess how changes in the external stimuli can influence the
structures and the function of a complex organ. Neuronal circuits are able to dynamically refine in
response to the huge amount of signals that we are exposed to from our birth (and before) through
the rest of our life, resulting in the complexity of our behavior.
The new field of epigenetics seems to be perfect to explain the molecular mechanisms
underlying one of the most exciting properties of the brain: its plasticity. Experience-dependent
plasticity is the capacity of neuronal circuits to remodel themselves and undergo modifications
based on changes in activity and sensory inputs. Plastic phenomena are present at different
levels: structural, such as changes in the circuitry and in synaptic connections, or molecular
such as modifications in the chromatin landscape and ultimately in gene expression. Brain
cells depend on complex and highly regulated mechanisms to appropriately activate or silence
gene programs in response to inputs from the environment. These events are controlled
by activity-dependent signaling pathways that mediate gene expression by modifying the
activity, localization, and/or expression of transcriptional-regulatory enzymes in combination
with alterations in chromatin structure in the nucleus (McClung and Nestler, 2008). Therefore,
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epigenetic mechanisms seem to play a key role in sustaining
the transcriptional program responsible for the establishment
and refinement of synaptic connections and neuronal circuits
especially during development but not only. Recent studies
indicate that alterations in chromatin state and gene expression
are important for mediating various aspects of experience-
dependent plasticity, such as developmental plasticity (e.g.,
visual cortical plasticity), learning and memory, and maladaptive
plasticity (e.g., drug of abuse responses).
Conrad H. Waddington (1905–1975) was the first to
introduce the idea of an ‘‘epigenetic landscape’’ (Waddington,
1957), to represent the process of cellular decision making
during development (Goldberg et al., 2007). The modern idea
of ‘‘epigenetics’’ goes beyond this concept and is defined as
the study of heritable changes in gene expression that occur
without changes in DNA sequence (Wolffe and Guschin, 2000).
Nevertheless the concept of an ‘‘epigenetic landscape’’ might be
applied to differentiated cells like neurons that are continuously
targeted by different inputs and choose their fate (to make or not
a synaptic contact, to spike or not, to wire in a particular circuit)
in accordance to the predominance of specific environmental
stimuli that ultimately remodel the chromatin structure to
activate or silence gene expression.
Neuroepigenetics has been a growing field for the last
decade and its research is converging on the study of
covalent and noncovalent modifications of DNA and histone
proteins and the mechanisms by which such modifications
influence overall chromatin structure, gene programs,
neuronal differentiation and plasticity, synaptogenesis and
finally complex behaviors. Due to important discoveries
in the last few years, in our review, we are focusing on
covalent DNA modifications especially methylation and
hydroxylmethylation involved in experience-dependent brain
plasticity.
DNA Methylation and its Regulation
DNA methylation is a covalent modification that occurs
on cytosine mostly located in CG dinucleotides (CpG) by
means of a reaction catalysed by a family of enzymes called
DNA methyltransferases (DNMT). This modification is known
to have a role in the constitutive silencing of chromatin
regions, the inactivation of one of the X chromosomes in
females, the imprinting of parental alleles, and the silencing
of retroviral genes and other individual genes (Ng and Bird,
1999). DNMT, a highly conserved family of proteins, transfer
a methyl group from S-adenyl methionine (SAM) to the
fifth carbon of a cytosine residue to form 5-methyl-cytosine
(5mC; Moore et al., 2013). In mammals, there are three
major DNMT: DNMT1, DNMT3a and DNMT3b. DNMT3a
and DNMT3b, the so-called de novo DNMT, were cloned
by Okano et al. (1999) and are responsible for establishing
the pattern of methylation in embryonic development. These
two enzymes show equal activity toward both unmethylated
and hemimethylated DNA (Okano et al., 1999). On the other
hand, the maintenance enzyme, DNMT1, shows a strong
preference for hemimethylated sites, generated during DNA
synthesis (Hermann et al., 2004). DNA methylation and its
enzymes have been extensively investigated in the development
of the embryo. Intriguingly, postmitotic neurons express high
levels of DNMT suggesting a different and new role for these
proteins and 5mC in the brain (Goto et al., 1994; Feng et al.,
2005).
DNA methylation has been thought to be a static epigenetic
mark for over 20 years. Recent evidence demonstrated that
is dynamically regulated both through passive and active
mechanisms. Passive DNA demethylation has been found
in mitotic cells. During cell division the pattern of DNA
methylation is maintained by DNMT1 (Sharif et al., 2007;
Berkyurek et al., 2014). If this DNMT is inhibited or its
activity is impaired or decreased, the new synthetized DNA
strand is not methylated any more, allowing to a gradual
decrease of cytosine methylation during the following divisions.
Active DNA demethylation occurs both in plants and mammals
and requires enzymes and reactions able to remove the
methyl group located on the pyrimidine ring of cytosine. A
single enzyme capable of breaking the strong Carbon-Carbon
bound in order to directly demethylate the cytosine has not
been found yet. However, cytosine demethylation can occur
through a series of chemical reactions of deamination and/or
oxidation.
One possible way involves the base excision repair (BER)
pathway. 5mC is deaminated by activation-induced cytidine
deaminase/apolipo-protein B mRNA-editing enzyme complex
(AID/APOBEC) and converted to a thymine. The base mismatch
is subsequently repaired by the BER pathway, through the
insertion of an unmethylated cytosine. The nucleotide excision
repair (NER) is an alternative method to remove 5mC, which
is generally used to repair DNA containing bulky lesions
caused by exposure to chemicals or radiation. GADD45a and
GADD45b have been implicated in NER dependent DNA
demethylation (Barreto et al., 2007; Ma et al., 2009). The
most interesting pathway proposed to participate in active
demethylation of DNA is the oxidative demethylation. Anjana
Rao’s group found ten eleven translocation enzyme (TET)
proteins as the mammalian homologs of the trypanosome
proteins J-binding protein 1 (JBP1) and JBP2, enzymes able
to oxidize the 5-methyl group of thymine. For the first
time they demonstrated that TET1, a Fe(II)/α-ketoglutarate-
dependent dioxygenase, is able to catalyse the conversion of
5mC to 5-hydroxymethylcytosine (5hmC) in vitro (Tahiliani
et al., 2009). Later, a similar enzymatic activity was found for
TET2 and TET3 too (Ito et al., 2010). Moreover, 5hmC can
be further oxidize to 5-formyl-cytosine (5fC) and 5-carboxy-
cytosine (5caC; He et al., 2011; Ito et al., 2011), however
their levels are significantly lower than that of 5hmC. The
discovery of TET enzymes has raised the intriguing possibility
for new roles of different oxidised states of cytosine in gene
expression control and in the dynamic regulation of DNA
methylation.
5hmC is particularly abundant in the central nervous system
(CNS) relative to many other tissues. Intriguingly, 5hmC in the
brain is 10-fold higher than in embryonic stem cells (ESCs;
Globisch et al., 2010; Song et al., 2011) highlighting a possible role
Frontiers in Cellular Neuroscience | www.frontiersin.org 2 August 2015 | Volume 9 | Article 331
Tognini et al. DNA methylation in neural plasticity
for hydroxyl methylation in the epigenetic control of neuronal
function.
Cytosine Covalent Modifications and
Neuronal Plasticity
In the last decade, emerging evidence emphasizes epigenetic
modifications as key players in brain plasticity. Recently, DNA
methylation and hydroxyl methylation have been the major
focus, being involved in a variety of fundamental processes
in the CNS: neuronal stem cell differentiation (Juliandi et al.,
2010), environmental programming of molecular, hormonal and
behavioral responses (Meaney and Szyf, 2005; Champagne, 2008;
Caldji et al., 2011) and synaptic plasticity (Heyward and Sweatt,
2015).
DNMT1 and DNMT3a levels remain high in post mitotic
neurons, implying a specific role for these enzymes in the
adult brain that goes beyond the classic view of de novo
and maintenance DNMT. For instance the double, but not
the single, knock-out (KO) mouse model of Dnmt3a and
Dnmt1 in forebrain excitatory neurons shows impairment
in hippocampal plasticity and learning and memory (Feng
et al., 2010), suggesting redundant activity of these DNMT
in mature neurons. Furthermore, DNMT1 and DNMT3a
have been demonstrated to be the protagonists of a variety
of different forms of neuronal plasticity in the adult, such
as fear- related memory (Miller and Sweatt, 2007), drug
addiction and emotional behavior (LaPlant et al., 2010),
and age associate decline in cognitive abilities (Oliveira
et al., 2012). Together with the modulation in DNMT
expression, changes in CG methylation on the promoter of
specific plasticity genes have shaded new light on the role
of experience-dependent methylation of DNA in the CNS.
Indeed, GADD45b is necessary for activity dependent DNA
demethylation on Bdnf exon IX and fibroblast growth factor 1
(Fgf1) promoters, critical genes involved in adult neurogenesis in
the hippocampus (Ma et al., 2009). Moreover, fear conditioning
is associated with rapid methylation and transcriptional silencing
of the memory suppressor gene Pp1 and demethylation and
transcriptional activation of the synaptic plasticity gene Reelin,
indicating dynamic and opposite methyl cytosine changes during
memory consolidation in the hippocampus (Miller and Sweatt,
2007).
DNA methylation might be exploited by neurons to achieve
dynamic changes in transcriptional activity during memory
formation that could be maintained with acquisition of the
memory trace. In line with this idea, contextual fear conditioning
has been shown to cause hypermethylation of the calcineurin
gene in the prefrontal cortex of rats and notably, this increase
in 5mC persists after 1 month from the training even if
calcineurin levels go back to their baseline. Nonetheless, rats
fail to display normal memory under infusion of DNMT
inhibitors in the anterior cingulate, a region of the dorsa-medial
prefrontal cortex involved in retrieval (Frankland et al., 2004),
30 days after the training (Miller et al., 2010). These results
strongly support the idea that DNA methylation is a critical
epigenetic mark for remote memory stability in the adult brain.
Importantly, the size of the change in methylation is not big,
rarely surpassing a 20% change. Whether this is due to the
fact that physiological activity exerts a modulatory effect on
methylation levels, or to the inherent difficulty of using neural
tissue homogenates that comprises different cell types possibly
diluting cell specific effects, is still to be ascertained. Studies
dedicated to cell-specific investigations are needed to solve this
issue (see below).
Finally, a comprehensive study gave a global overview of
the activity-dependent neuronal methylome in the granules of
the dentate gyrus, showing how external stimuli can quickly
modify the methylation landscape of mature neurons in vivo
(Guo et al., 2011a). It is worth noting that the level of 5hmC is
very high in the brain and that the classic bisulfite sequencing
analysis is not able to distinguish between 5mC and 5hmC
(Huang et al., 2010). Base-resolution sequencing of 5hmC and
5mC using a method that can distinguish between the two
modifications found that 4.2% of total cytosines are 5mC
and 0.87% are 5hmC, which represents a 20% difference in
quantification if 5hmC are incorrectly called as 5mC (Lister
et al., 2013). Not surprisingly, the high content of 5hmC
in the brain has caught the attention of neuroscientists in
the last few years prompting them to elucidate the influence
of hydroxyl methylation on epigenetic dynamics in neurons.
The first genome-wide map of 5hmC in neuronal tissue was
performed on mouse cerebellum and hippocampus at different
stages of mouse life: development, adulthood and ageing. The
authors found a strong increase in 5hmC from the early
postnatal stage of development to adulthood suggesting a robust
correlation with neurodevelopment (Szulwach et al., 2011). It
would be interesting and meaningful to extend this type of high
throughput analysis to all the different neurons and glial cells
present in the diverse brain areas to understand how plastic and
cell-specific are the brain methylome and hydroxylmethylome.
A first step in this direction was made by Heintz’s group.
Using the translating ribosome affinity purification technique to
isolate the cell-specific transcriptome, and fluorescence activated
cell sorting of EGFP/L10a labeled soma to isolate the cell-
specific methylome and hydroxylmethylome, they performed a
comparison between the transcriptome and the genome wide
distribution of 5mC and 5hmC in cerebellar cell types in vivo.
Purkinje cells, granule cells, and the terminally differentiated and
specialized Bergmann glial cells were compared. Interestingly,
specific gene expression and covalent DNAmodifications profile
were present in the different types of cells (Mellén et al.,
2012).
Although many efforts have been made to explain the
role of 5hmC, its function as a stable epigenetic mark or a
labile reaction intermediate is still an open question that has
been addressed in previous reviews (Hahn et al., 2014; Sun
et al., 2014). It has been proposed that 5hmC might be the
intermediate of a quick demethylation, re-methylation and again
oxidation cycle. In line with this hypothesis are the high level
of DNMT3a in neuronal nuclei and its association with TDG
(Feng et al., 2005; Li et al., 2007). However, this model does
not explain why 5fC and 5caC are so low with respect to
5hmC, as detected by sensitive mass spectrometry techniques
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(Liu et al., 2013). Thus, 5hmC could be a stable mark exerting
a specific regulatory role. 5hmC is abundant in gene bodies
and promoter regions of active genes providing correlative
evidence for a role in gene expression regulation. This role is
also suggested by the observation that 5hmC is recognized by
unique epigenetic readers in diverse cells (Spruijt et al., 2013).
For example, methyl CpG binding protein 2 (MeCP2), one of the
most studied 5mC readers, is able to bind hydroxylated cytosine
with affinity comparable to methylated cytosine. Moreover,
the binding of MeCP2 to 5hmC in expressed genes seems
to facilitate transcription through organization of dynamic
chromatin domains. However, the functional significance of this
interaction remains unclear. Intriguingly, R133C substitution,
one the most well known mutations in MeCP2 underlying Rett
syndrome (RTT), loses its specific binding capability to 5hmC
despite retaining the binding to 5mC (Mellén et al., 2012).
This discovery gives new insights on the physiological role of
MeCP2 in chromatin structure and organization and might
help to better understand crucial molecular mechanisms for the
pathophysiology of RTT. RTT is an example of a disease caused
by an alteration of a 5mC and 5hmC reader, however several
other neurodevelopmental disorders of genetic origin are caused
bymutations of factors involved inDNAmethylation (seeBox 1),
underscoring the importance of DNA methylation for brain
function.
A fundamental question to address has been if dynamic
hydroxylation and methylation of DNA in neurons are
activity-dependent. The adult brain has been the most
investigated scenery so far. Electroconvulsive stimulation
induces demethylation of Bdnf exon IX and Fgf1 promoter in the
dentate gyrus through a mechanism involving TET1 dependent
hydroxylation and APOBEC1 deamination (Guo et al., 2011b).
Similarly, status epilepticus and epileptic tolerance are able
to induce a particular methylation profile in the hippocampal
genome of adult mice confirming how an aberrant neuronal
activity can quickly and specifically modulate the epigenetic
landscape in neuronal cells (Miller-Delaney et al., 2012). TET1
is regulated by electrical stimulation in the hippocampus
and its hydroxylase activity drives active demethylation.
Overexpression of TET1 and of a catalytically inactive form
of TET1 in the hippocampus impairs long-term associative
memory and expression of plasticity genes, suggesting a new,
however not yet investigated, hydroxylase-independent role
of TET1 in regulating transcription and memory formation
(Kaas et al., 2013). Although the deficiency of TET1 in mouse
is compatible with embryonic and postnatal development
(Dawlaty et al., 2011), loss of Tet1 alters the maintenance of the
neuronal progenitor pool causing a reduction in neurogenesis
in the dentate gyrus. The proposed mechanism consists in
the transcriptional repression of neurogenesis-related genes
due to hypermethylation of their promoter. Consistent with
an impaired adult neurogenesis, Tet1 null mice displayed
defective cognitive functions, specifically in the acquisition
of spatial memory (Zhang et al., 2013). Furthermore, in Tet1
null mouse model long term depression (LTD) is abnormally
enhanced and they fail to exhibit memory extinction, a form
of inhibitory learning that provides a basis for an adaptive
control of cognition. Cognitive and synaptic deficits are
BOX 1 | DNA Methylation and Neurodevelopmental Disorders
Several neurodevelopmental disorders are characterized by mutations in epigenetic proteins implicated in DNA methylation mechanisms, suggesting that disrupting
this chromatin feature can induce severe developmental defects.
1. Rett Syndrome (RTT). RTT is a postnatal neurological disorder that results in serious intellectual and motor disability. In the majority of cases, it is caused
by loss of function mutations in the X-linked gene Methyl CpG binding protein 2 (MeCP2; Della Sala and Pizzorusso, 2014). Originally MeCP2 was thought to
bind only methylated CG dinucleotide (Lewis et al., 1992), recently it was discovered that it can bind with high affinity 5hmC and mCH (Mellén et al., 2012;
Guo et al., 2014).
2. Immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome. ICF syndrome is a rare autosomal recessive disorder characterized
by immunodeficiency, intestinal dysfunction, mental retardation, psychomotor impairment and particular facial features (Ehrlich, 2003). In 60–70% of ICF
patients there is a mutation in the Dnmt3b gene (Xu et al., 1999), generally in the catalytic domain. The result is chromosomal instability caused by
hypomethylation of pericentromeric chromatin. Moreover bisulfite sequencing analysis in limphoblastoid cells from ICF patients showed a marked decrease
in DNA methylation occurring in heterocromatic regions, satellite repeats and transposons, clearly underling a robust remodeling of the epigenetic landscape in
consequence of DNMT3b aberrant function (Heyn et al., 2012).
3. Alpha-thalassemia X-linked intellectual disability (ATRX) syndrome. Persons affected by ATRX syndrome present distinctive craniofacial features,
genital anomalies, severe developmental delays, hypotonia, intellectual disability, and mild-to-moderate anemia secondary to alpha-thalassemia. The disorder
is caused by mutations in ATRX gene, a SWI/SNF helicase/ATPase. Intriguingly, ATRX has been demonstrated to interact with MeCP2 and in MeCP2 null-brain
ATRX delocalizes from the heterocromatic foci suggesting that this interaction is important for ATRX and MeCP2 function in the context of a correct neuronal
development (Nan et al., 2007). Furthermore, mutations in ATRX give rise to modifications in the pattern of DNA methylation of several highly repeated
sequences (Gibbons et al., 2000).
4. 2q23.1 Microdeletion syndrome. This rare neurodevelopmental disorder is characterized by partial or complete deletion of Methyl binding protein 5 (MBD5).
The subjects show severe intellectual deficits, epilepsy and autistic features (Talkowski et al., 2011).
In addition, abnormalities in genomic imprinting (exclusive expression of specific genes from only one parent, induced by the silencing of one of the two alleles through
DNA methylation and other epigenetic mechanisms) can cause neurodevelopmental disorders such as Prader-Willi syndrome and Angelman syndrome (Weissman
et al., 2014). Expansion and aberrant methylation of CGG repeats on the first exon of Fmr1 gene are responsible for the loss of its protein product FMRP and the
development of Fragile X syndrome, a commonly inherited form of intellectual disability and one of the genetic leading causes for autism spectrum disorders (ASD;
Wang et al., 2012).
Finally, genome wide association studies have been starting to reveal how changes in DNA methylation might be involved in ASD, a very complex class of
neurodevelopmental diseases caused by a combination of genetics and environment (for a comprehensive review about the argument, see Loke et al., 2015).
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accompanied by gene expression impairments, in particular
by a downregulation in neuronal activity regulated genes
such as Npas4, whose promoter is hypermethylated both in
the cortex and hippocampus of Tet1 ko animals (Rudenko
et al., 2013). Recently, TET1 has been implicated in the
molecular and behavioral effects of cocaine. After chronic
cocaine administration TET1 is downregulated in the nucleus
accumbens of adult mice and 5hmC is increased at putative
enhancer regions and gene bodies (Feng et al., 2015). These
results are not totally in agreement with previous research on
learning and memory, in which a decrease in TET1 caused
less 5mC hydroxylation and thus to hypermethylayion and
transcriptional repression (Kaas et al., 2013; Rudenko et al.,
2013; Zhang et al., 2013). However, the addiction data focuses on
changes in 5hmC in gene bodies more than on promoters, and
on a genome wide scale, suggesting a much more complicated
level of epigenetic regulation for hydroxylated DNA and TET
enzymes in the brain.
Although TET1 is the less expressed isoform in the adult
brain (Szwagierczak et al., 2010), it has been the protagonist
of the majority of the research in the field. Recent studies
have concentrated their attention on the role of TET3, the
most abundant TET in both cortex and hippocampus, in
behavioral adaptation and homeostatic plasticity (Li et al.,
2014; Yu et al., 2015). TET3 is activity-dependent in cortical
neurons in vitro and is induced after fear extinction learning
in the infra-limbic prefrontal cortex of rodents. Furthermore,
extinction is able to cause a TET3 dependent redistribution
and accumulation of 5hmC in the prefrontal cortex, creating a
transcriptional permissive chromatin environment especially for
a key gene in the organization of the postsynaptic side of the
inhibitory synapse, such as Gephyrin (Li et al., 2014). In cultured
hippocampal neurons TET3 levels are regulated by electrical
activity and TET3 itself is involved in modulation of basal
excitatory synaptic transmission and synaptic scaling through
changes in the glutamate receptor Glur1 surface expression
(Yu et al., 2015). Finally, TET2 has been identified as the
TET enzymes responsible for 5hmC mark in the fetal brain of
putative regulatory regions that are demethylated and activated
in the adult animal, suggesting that TET2 mediates 5mC
demethylation during neuronal development (Lister et al., 2013).
However, there are no reports implicating TET2 in activity-
dependent gene expression control. Unlike DNMT enzymes
that seem to have, at least in part, a redundant role in the
adult brain (Feng et al., 2010), each TET enzyme seems to
play a more specific role. Future research will unveil the
specific function and regulation of TET activity in brain
plasticity.
It is becoming clear that covalent modifications of DNA are
a powerful epigenetic tool to fine-tune neuronal functions and
synaptic plasticity. Hydroxylation and methylation of cytosine
have been extensively studied in the context of embryonic
development and in the adult brain, giving exciting insights
on their role in neuronal differentiation and reprogramming of
pluripotent stem cells or in complex behavioral processes, such
as learning and memory. In the next paragraph, we will review
recent data showing that experience-dependent regulation of
DNA methylation and hydroxyl methylation could be even
more dynamic in juvenile animals during developmental critical
periods of heightened plasticity (Tognini et al., 2015).
Experience-Dependent DNA Methylation
During Post-Natal Development
The visual system has long been one of the most investigated
models to study experience-dependent plasticity because visual
experience can be easily manipulated and the subsequent effects
can be measured at the anatomical, physiological and molecular
level. The maturation of the visual circuitry starts before the
eye-opening and therefore before the onset of vision, although
experience is necessary for a correct development of the visual
system, especially during a specific window of time called
the critical period. In rodents, the critical or sensitive period
covers an interval between 3 and 7 weeks of life. During
this sensitive period of heightened plasticity, experience is
particularly effective in producing permanent and extensive
modifications of cortical organizations (Spolidoro et al., 2009;
Espinosa and Stryker, 2012; Levelt and Hübener, 2012; Takesian
and Hensch, 2013).
Ocular dominance plasticity (ODP) consists in a rapid
modification in the responses of visual cortical neurons, which
results from unbalanced visual input from the two eyes. A
large variety of mechanisms have been proposed to contribute
to ODP and critical period plasticity in general (Levelt and
Hübener, 2012). For example, extracellular matrix composition
and axon myelinisation (Pizzorusso et al., 2002, 2006; McGee
et al., 2005), maturation of inhibitory circuits that changes the
excitatory/inhibitory balance making the circuitry less favorable
to plasticity (Hensch and Fagiolini, 2005; Gandhi et al., 2008;
Yazaki-Sugiyama et al., 2009; Iurilli et al., 2013; Saiepour
et al., 2015), CREB dependent gene expression (Pham et al.,
1999; Mower et al., 2002; Cancedda et al., 2003) and histone
post-translational modifications (Putignano et al., 2007) have
all been proposed to contribute to critical period closure.
Recently, a CREB dependent microRNA, miR-132 has been
shown to be a key player in the regulation of ODP in the
developing visual cortex (Mellios et al., 2011; Tognini et al.,
2011). MiR-132 expression levels correlate with changes in
epigenetic marks, such as acetylation and phosphorylation
of the histone H3, induced by visual stimuli manipulations
(Tognini et al., 2011). Monocular deprivation (MD, the suture
of one eye), the classic paradigm to study ODP, is able to
downregulate miR-132 in the visual cortex contralateral to the
deprived eye. Strikingly, counteracting miR-132 downregulation
through the infusion of chemically modified miRNA mimic in
the cortex, or further reducing miR-132 through injection of
a lentivirus expressing a miR132-sequestering sponge, during
MD completely prevents ODP in young mice (Mellios et al.,
2011; Tognini et al., 2011). Interestingly, the miR-132 genomic
locus, that contains both miR-132 and miR-212 transcripts
(Tognini and Pizzorusso, 2012), lies in a region enriched in CG
dinucleotides, although the significance of miR-132 locus CpG
methylation in neural cells has been totally unexplored. In a
new study, Tognini et al. (2015) demonstrated that the effects
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of visual deprivation on miR-132 expression is regulated by a
dynamic switch in DNA methylation and hydroxyl methylation
after 3 days of MD in the visual cortex of juvenile mice.
Moreover, Gadd45a, b and g are all downregulated. GADD45
family members participate in active DNA demethylation and
have been previously shown to be involved in plasticity (Leach
et al., 2012; Sultan et al., 2012; Sultan and Sweatt, 2013).
Their reduction in the deprived cortex, combined with the
increase in DNMT expression, results in an enhancement of
DNA methylation in the deprived cortex on specific DNA
loci. Single-base resolution analysis of 5mC on the promoter
region of well-known plasticity genes downregulated by MD
during the critical period, miR-132 and Bdnf exon4 transcript
(Hong et al., 2008; Mellios et al., 2011; Tognini et al., 2011),
demonstrates a significant increase in DNA methylation in the
visual cortex contralateral to the deprived eye. Remarkably,
5hmC shows an opposite behavior on the same DNA loci
suggesting that sensory inputs are able to dynamically modulate
cytosine states to control experience-dependent gene expression
(Figure 1). It is worth noting that MD does not modify DNA
methylation and hydroxyl methylation patterns in adult mice
strongly connecting these dynamic changes to cortical plasticity
levels. Strikingly, the pharmacological inhibition of DNMT
counteracts experience-dependent downregulation of miR-132
and Bdnf exon 4 in the deprived visual cortex. To analyze
the importance of DNMT activity for experience-dependent
regulation of gene transcription in the visual cortex at whole
transcriptome level, the authors performed RNA sequencing
analysis of deprived mice and of mice treated with the DNMT
inhibitor RG108. It was found that for about 13.5% of the genes
regulated by MD, DNMT inhibition prevents the effects of visual
deprivation. Since DNMT inhibition never exerts the opposite
effect, i.e., enhancing the effect of deprivation, these data suggest
that DNMT activity is necessary for a significant component
of the transcriptional program activated by MD during the
critical period. The DNMT-dependent part of the transcriptional
program activated by MD is essential for visual cortical
plasticity, indeed electrophysiological investigation revealed
that ODP is completely blocked in the cortex treated with
DNMT inhibitor. Taken together, these results reveal that visual
deprivation has opposite effects on DNA methylation and
hydroxyl methylation on specific genomic regions and suggest
that these modifications could be brought about by the visual
regulation of DNMT, GADD45 and APOBEC-3 expression
and possibly their DNA binding. For the first time, dynamic
modifications of DNA have been implicated in mediating
visual experience-dependent modulation of transcription of
a selected gene set necessary for the molecular processes
underlying ODP.
This finding represents just the first step to unravel how
sensory inputs can modulate covalent cytosine modifications
in order to refine the cortical circuits during development.
The study points out how visual experience through DNA
methylation and hydroxyl methylation dynamics is able to
influence the physiological property of cortical neurons during
the critical period. It would be interesting to check if these
DNA methylation changes represent a long lasting epigenetic
memory trace capable of affecting future behavioral responses in
adulthood.
Non-CpG DNA Methylation
Until few years ago, cytosine methylation was thought to be
restricted to CpG sites, because of their intrinsic symmetry
that facilitates the transmission of this epigenetic mark through
cell divisions (Schübeler, 2015). However, CpG are not the
only sites undergoing methylation. First reported in embryonic
and pluripotent cells (Ziller et al., 2011; Lister et al., 2013),
particularly high level of methylation in non-CpG cytosines
(mCH, where H stands for adenine A, thymine T or cytosine C)
has been found in the adult mouse and human brain genome
(Xie et al., 2012; Varley et al., 2013) and recently, in almost
all human tissues (Schultz et al., 2015). Both the non-CpG
methylated loci and the target sites found in the adult brain are
different from those in ESCs: CAC is the preferred trinucleotide
in neuronal cells and CAG in ESCs (Lister et al., 2013; Guo
et al., 2014). After these first observations, many questions
have been coming up about the distribution, function and cell-
specificity pattern of mCH in the adult brain. Using genome
wide single-base resolution analysis it has been found that
mCH is absent in the fetal cortex and accumulates in the
mouse and human brain in the early postnatal life becoming
the predominant form of DNA methylation (∼53% mCH vs.
∼47% mCG; Lister et al., 2013). Remarkably, the analysis
of sorted neuronal and glial cells revealed that high levels
of mCH are strongly enriched in neurons and just sparse
in glia suggesting that this form of DNA methylation might
be more relevant for neuronal-specific functions. Moreover,
gene ontology analysis shows that genes hypermethylated in
CH in glial cells are implicated in neuronal and synaptic
development and functions. On the other hand, the same genes
are hypomethylated in CH and CG in neurons, indicating that
mCH might have a transcriptional repressive role for neuronal-
specific genes in the glial genome (Lister et al., 2013). Notably,
the increase in mCH coincides with a postnatal developmental
window characterized by a burst in synaptogenesis followed
by activity-dependent pruning of excess synapses meaning
that neurons could use this modification to sculpt their gene
expression during critical periods. The identification of the
functional role of mCH is an emerging research field that
is still under intense study (for review, see He and Ecker,
2015). However, recent anti-correlation results between mCH
levels and gene expression suggest that mCH has the same
repressive function of mCG in differentiated cells (Lister et al.,
2013; Guo et al., 2014; Schultz et al., 2015). In vitro studies
manipulating mCH content to assess its role on transcriptional
activity using mCH methylated plasmids expressing GFP as
a reporter gene (Guo et al., 2014) confirmed the hypothesis
that mCH is repressive for gene transcription. However,
it is worth noting that mCH repressive action cannot be
generalized to all cell types. For instance, a correlation between
high levels of mCH and high levels of expression has been
observed in ESCs (Chen et al., 2011). These differences are
possibly due to distinct types of DNA methylation writers
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FIGURE 1 | (A) Loci studied in Tognini et al. (2015) to assess visual
experience regulation of 5mC and 5hmC. Arrows point the location
of the primers used for immunoprecipitation analysis of 5mC and
5hmC. (B) Sketch illustrating the results obtained on miR-212/132
CRE1 and CRE2–3 promoters and on promoter region of BDNF
exon4. Visual experience modulated in opposite direction 5mC and
5hmC abundance at these loci resulting in an increase of
5hmC/5mC ratio.
and readers present in each cell type. ESCs have a high
DNMT3b/DNMT3a expression ratio as opposed to mature
neurons showing very low levels of DNMT3b (Okano et al.,
1999; Lister et al., 2013; Tognini et al., 2015). DNMT3b is
able to catalyze the CH methylation reaction and recent work
suggests that is likely to be the major enzyme for mCH in
human ESCs (Liao et al., 2015). DNMT3b selectively binds to
the bodies of transcribed genes possibly by interacting with
H3K36Me3, a histone mark typical of actively transcribed genes
in ESCs (Baubec et al., 2015). This mechanism exemplifies how
mCH could have opposite functional effects in different cell
types.
As already mentioned, CpG methylation is catalyzed by
DNMT. DNMT3a shows a developmental expression timing
overlapping with the postnatal brain accumulation of mCH
(Lister et al., 2013). The role of DNMT3a in CH methylation is
also supported by data showing that knockdown with adeno-
associated virus of DNMT3a produces a reduction of mCH
levels that is not obtained with DNMT1 silencing (Guo et al.,
2014). Furthermore, ChIP results demonstrate the direct binding
of DNMT3a to mCH enriched regions (Lister et al., 2013).
Therefore, DNMT3a seems to be the principal writer of mCH
in differentiated neurons. Strikingly, MeCP2, a classic reader
of mCG, can bind also to mCH (Guo et al., 2014; Chen
et al., 2015; Gabel et al., 2015); in particular mCA is its
preferential target with comparable or even more affinity than
mCG. mCA is enriched in gene bodies of long genes (>100 kb),
preferentially expressed in the CNS (Gabel et al., 2015). Thus,
the deleterious effects of MeCP2 loss of function in RTT could
be due to the upregulation of a specific set of genes consisting
in the genes with length >100 kb. Importantly, the transcription
of long genes is dependent on topoisomerases (King et al.,
2013) raising the possibility that pharmacological inhibition
of topoisomerases might be beneficial in RTT. In agreement
with this theory, topoisomerase inhibition in knocked-down
MeCP2 neuronal cultures induces a dose-dependent reversal of
long gene expression. It remains to demonstrate if the in vivo
use of this pharmacological compound could reverse also the
phenotype of RTT mouse models. Considering the importance
of DNA methylation for neuronal functions, it is likely that
future studies will discover a role for mCH also in other brain
pathologies.
Conclusions and Perspectives
Epigenetic regulation of gene expression is one of the most
fascinating research areas. Many exciting discoveries have
been made during the last decade, however we still need
to address many questions. Scientists have started to unravel
the existence of an intricate ‘‘neuronal epigenetic code’’,
important for cells differentiation, brain development and
plasticity both in physiology and pathology. The brain has
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an exceptional and unique epigenetic feature with respect
to all the other tissues in our body, both referring to the
abundance of specific epigenetic marks: 5-hydroxyl methylation
on cytosine, non-CG methylation, and to an extremely plastic
epigenetic landscape due to the continuous stimulation from
the environment. We are just beginning to understand how
specific epigenetic marks are regulating gene expression in
response to exogenous and endogenous inputs and how
remodeling of the chromatin milieu can contribute to the
modifications in the structure and anatomy of neuronal
circuitry.
Another level of complexity to the study of chromatin
architecture in neurons consists in the regulation of enzymes
responsible to read, write and erase epigenetic marks. It has been
demonstrated that cofactors (i.e., NAD) and metabolites (i.e.,
Acetyl- CoA, Beta-hydroxybutirate, alpha-ketoglutarate) are able
to influence the activity of enzymes, such as acetyl transferases,
deacetylases and TET (Xu et al., 2011; Shimazu et al., 2013;
Pietrocola et al., 2015). Therefore, the nutritional state and
the lifestyle can modulate the activity of epigenetic enzymes
and subsequently the chromatin structure, connecting again
environment and gene expression. Although still in its infancy,
the epigenetic link between brain plasticity and metabolic state
seems to be a new promising and exciting research field.
Finally, the mammalian brain is a very complicated and
heterogeneous organ characterized by functionally different
areas and a huge variety of cell populations. Neural and
glial cells are characterized by a unique microenvironment,
a broad ranging interconnectivity and indeed, might have a
different and exclusive epigenome and transcriptome. So far,
DNA methylation and histone posttranslational modifications
related to plasticity processes have been assessed mostly in
tissue homogenates, comprising together heterogeneous cells
(excitatory and inhibitory neurons, glial cells etc.) and potentially
masking the diversity of cell-specific epigenetic marks or gene
expression. The solution to this challenge is a single-cell analysis
(i.e., laser capture microdissection, fluorescence activated cell
sorting) that present some obstacles due to high costs, low
yield of specific cell types, and cell manipulation prior to
analysis. An effort in this direction has been recently made
via the utilization of INTACT (isolation of nuclei tagged
in specific cell types (Deal and Henikoff, 2010) to isolate
and examine the genetic and epigenetic features of some
classes of neocortical neurons in the mouse brain: excitatory
pyramidal neurons, parvalbumin-expressing and vasoactive
intestinal peptide-expressing interneurons (Mo et al., 2015).
This study underlined fundamental differences between the
transcriptome and the methylome in different neuronal subtypes
in the healthy brain. It would be interesting to apply this
technique to the developmental brain and to neurological
disease models to unravel how plastic is the neuron-specific
genome and epigenome in response to environmental and
pathological cues.
The future advancement in technology will hopefully shed
new light on the intricate epigenetic mechanisms regulating
neuronal plasticity and function providing novel directions
to create better therapeutic interventions for neuropsychiatric
symptoms in humans.
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